JP2022551911A5 - - Google Patents
Info
- Publication number
- JP2022551911A5 JP2022551911A5 JP2022521637A JP2022521637A JP2022551911A5 JP 2022551911 A5 JP2022551911 A5 JP 2022551911A5 JP 2022521637 A JP2022521637 A JP 2022521637A JP 2022521637 A JP2022521637 A JP 2022521637A JP 2022551911 A5 JP2022551911 A5 JP 2022551911A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- viral vector
- approximately
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962912958P | 2019-10-09 | 2019-10-09 | |
| US62/912,958 | 2019-10-09 | ||
| PCT/US2020/055082 WO2021072272A1 (en) | 2019-10-09 | 2020-10-09 | Epicardial delivery of gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551911A JP2022551911A (ja) | 2022-12-14 |
| JP2022551911A5 true JP2022551911A5 (https=) | 2023-10-17 |
Family
ID=75437778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521637A Pending JP2022551911A (ja) | 2019-10-09 | 2020-10-09 | 遺伝子治療の心外膜送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240115732A1 (https=) |
| EP (1) | EP4041192A4 (https=) |
| JP (1) | JP2022551911A (https=) |
| CN (1) | CN115151262A (https=) |
| CA (1) | CA3153845A1 (https=) |
| WO (1) | WO2021072272A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024233783A1 (en) * | 2023-05-09 | 2024-11-14 | Cornell University | Expression cassette coding for vascular endothelial growth factor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU745409B2 (en) * | 1997-01-29 | 2002-03-21 | Cornell Research Foundation Inc. | Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| US6197324B1 (en) * | 1997-12-18 | 2001-03-06 | C. R. Bard, Inc. | System and methods for local delivery of an agent |
| US20060084622A1 (en) * | 1998-03-11 | 2006-04-20 | Technion Research & Development Co., Ltd. | Angiogenic factor and use thereof in treating cardiovascular disease |
| US7288521B2 (en) * | 2000-04-06 | 2007-10-30 | Franco Wayne P | Growth factor therapy mobilization of stem cells into the peripheral blood |
| AU2003291526A1 (en) * | 2002-11-15 | 2004-06-15 | Genvec, Inc | Coronary artery disease treatment |
| EP3329779B1 (en) * | 2012-11-02 | 2019-06-05 | Cornell University | Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium |
| EP2925863B1 (en) * | 2012-11-30 | 2020-07-15 | Vestion Inc. | Cardiac stem cells and methods of identifying and using the same |
-
2020
- 2020-10-09 EP EP20873776.7A patent/EP4041192A4/en not_active Withdrawn
- 2020-10-09 US US17/767,524 patent/US20240115732A1/en not_active Abandoned
- 2020-10-09 JP JP2022521637A patent/JP2022551911A/ja active Pending
- 2020-10-09 CN CN202080083691.XA patent/CN115151262A/zh active Pending
- 2020-10-09 CA CA3153845A patent/CA3153845A1/en active Pending
- 2020-10-09 WO PCT/US2020/055082 patent/WO2021072272A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hughes et al. | Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF | |
| Sasano et al. | Targeted high-efficiency, homogeneous myocardial gene transfer | |
| Hendren et al. | Extracorporeal bypass for the treatment of verapamil poisoning | |
| Katz et al. | Gene delivery technologies for cardiac applications | |
| CN101370486B (zh) | 含有硝酸异山梨酯和比索洛尔的透皮贴剂 | |
| Lorell et al. | Modification of left ventricular response to pacing tachycardia by nifedipine in patients with coronary artery disease | |
| JP2022551911A5 (https=) | ||
| JP2025148449A5 (https=) | ||
| Yasmeen et al. | A novel approach to devise the therapy for ventricular fibrillation by epicardial delivery of lidocaine using active hydraulic ventricular attaching support system: an experimental study in rats | |
| Abo-Auda et al. | Therapeutic angiogenesis: review of current concepts and future directions | |
| Jolly et al. | Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol | |
| JP2023020885A5 (https=) | ||
| Farraha et al. | Therapeutic prospects of gene therapy for atrial fibrillation | |
| Taira et al. | Sustained coronary constriction and its antagonism by calcium-blocking agents in monkeys and baboons | |
| CN111467348A (zh) | 一种n-(噻唑-2-基)-3-(哌嗪-1-基)丙酰胺类衍生物在药物制备中的应用 | |
| JP2016510040A5 (https=) | ||
| Drumheller et al. | Hemodynamic instability and abnormal vasopressor responsiveness in the setting of severe metabolic acidosis treated with adapted alkalinization and continuous renal replacement therapy in the emergency department | |
| Huang et al. | Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows | |
| JP2024517204A5 (https=) | ||
| Kendrick et al. | Amiodarone treatment of junctional ectopic tachycardia in a neonate receiving extracorporeal membrane oxygenation | |
| Marbán et al. | Gene therapy for cardiac arrhythmias | |
| Hokimoto et al. | Atrioventricular nodal ablation and biventricular pacing therapy with coronary venoplasty for severe heart failure with drug refractory atrial tachycardia | |
| Sundaravel et al. | Methylene blue to the rescue in accidental treprostinil overdose | |
| JP2021512148A5 (https=) | ||
| White et al. | Beneficial effects of prolonged low dose dopamine in hospitalized patients with severe refractory heart failure |